Loading...
CLS Holdings USA, Inc.
CLSH.CN•CNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.04
CA$-0.01(-22.22%)
CLS Holdings USA, Inc. (CLSH.CN) Financial Performance & Income Statement Overview
Review CLS Holdings USA, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-13.71%
↓ 13.71%
Operating Income Growth
46.90%
↑ 46.90%
Net Income Growth
67.48%
↑ 67.48%
Operating Cash Flow Growth
451.82%
↑ 451.82%
Operating Margin
-8.66%
↓ 8.66%
Gross Margin
41.67%
↑ 41.67%
Net Profit Margin
2.62%
↑ 2.62%
ROE
-4.12%
↓ 4.12%
ROIC
14.46%
↑ 14.46%
CLS Holdings USA, Inc. (CLSH.CN) Income Statement & Financial Overview
Review CLS Holdings USA, Inc.'s (CLSH.CN) income statement with detailed quarterly and annual figures.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $3.85M | $4.16M | $4.81M | $4.72M |
| Cost of Revenue | $2.31M | $2.39M | $2.76M | $2.78M |
| Gross Profit | $1.54M | $1.77M | $2.05M | $1.95M |
| Gross Profit Ratio | $0.40 | $0.43 | $0.43 | $0.41 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $3182.00 |
| SG&A Expenses | $1.94M | $2.10M | $2.18M | $2.61M |
| Operating Expenses | $1.94M | $2.10M | $2.18M | $2.60M |
| Total Costs & Expenses | $4.25M | $4.48M | $4.94M | $5.38M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $114889.00 | $295715.00 | $159403.00 | $781595.00 |
| Depreciation & Amortization | -$671833.00 | $122043.00 | $134487.00 | $332380.00 |
| EBITDA | -$393169.00 | $798865.00 | -$2077.00 | $3.53M |
| EBITDA Ratio | -$0.10 | $0.19 | -$0.00 | $0.75 |
| Operating Income | -$393169.00 | -$323074.00 | -$136564.00 | -$667205.00 |
| Operating Income Ratio | -$0.10 | -$0.08 | -$0.03 | -$0.14 |
| Other Income/Expenses (Net) | $556944.00 | $704181.00 | -$159403.00 | $3.08M |
| Income Before Tax | $163775.00 | $381107.00 | -$295967.00 | $2.41M |
| Income Before Tax Ratio | $0.04 | $0.09 | -$0.06 | $0.51 |
| Income Tax Expense | -$442655.00 | $468778.00 | $524896.00 | $767180.00 |
| Net Income | $606430.00 | -$87671.00 | -$820863.00 | $1.65M |
| Net Income Ratio | $0.16 | -$0.02 | -$0.17 | $0.35 |
| EPS | $0.004 | $0.005 | -$0.007 | $0.02 |
| Diluted EPS | $0.004 | $0.005 | -$0.007 | $0.02 |
| Weighted Avg Shares Outstanding | $164.73M | $167.20M | $125.12M | $98.86M |
| Weighted Avg Shares Outstanding (Diluted) | $164.73M | $167.20M | $125.12M | $98.86M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan